ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,192 | +10.9% | 98,103 | +20.6% | 0.00% | – |
| Q2 2023 | $130,953 | -96.3% | 81,337 | -93.3% | 0.00% | – |
| Q1 2023 | $3,521,470 | +185.2% | 1,214,300 | +222.6% | 0.00% | – |
| Q4 2022 | $1,234,802 | -32.5% | 376,464 | -22.2% | 0.00% | – |
| Q3 2022 | $1,828,000 | -32.3% | 483,621 | +39.6% | 0.00% | – |
| Q2 2022 | $2,699,000 | +55.8% | 346,438 | +85.9% | 0.00% | – |
| Q1 2022 | $1,732,000 | -11.3% | 186,386 | +50.5% | 0.00% | – |
| Q4 2021 | $1,952,000 | +78.4% | 123,867 | +102.6% | 0.00% | – |
| Q3 2021 | $1,094,000 | +79.1% | 61,150 | +55.7% | 0.00% | – |
| Q2 2021 | $611,000 | -63.4% | 39,282 | -66.3% | 0.00% | – |
| Q1 2021 | $1,671,000 | +271.3% | 116,393 | +407.1% | 0.00% | – |
| Q4 2020 | $450,000 | -63.9% | 22,954 | -76.1% | 0.00% | – |
| Q3 2020 | $1,247,000 | +191.4% | 96,219 | +227.9% | 0.00% | – |
| Q2 2020 | $428,000 | -72.1% | 29,342 | -83.7% | 0.00% | – |
| Q1 2020 | $1,536,000 | +1.0% | 180,461 | +95.3% | 0.00% | – |
| Q4 2019 | $1,521,000 | -16.7% | 92,386 | -28.5% | 0.00% | – |
| Q3 2019 | $1,825,000 | -64.0% | 129,245 | -48.7% | 0.00% | -100.0% |
| Q2 2019 | $5,068,000 | -32.3% | 252,005 | +33.8% | 0.00% | 0.0% |
| Q1 2019 | $7,487,000 | +125.0% | 188,359 | +96.7% | 0.00% | 0.0% |
| Q4 2018 | $3,327,000 | -43.2% | 95,771 | -32.4% | 0.00% | 0.0% |
| Q3 2018 | $5,855,000 | -45.5% | 141,615 | -51.5% | 0.00% | -50.0% |
| Q2 2018 | $10,734,000 | -32.7% | 292,106 | -28.6% | 0.00% | -33.3% |
| Q1 2018 | $15,954,000 | +775.2% | 409,096 | +306.0% | 0.00% | – |
| Q4 2017 | $1,823,000 | -45.0% | 100,768 | -49.7% | 0.00% | -100.0% |
| Q3 2017 | $3,315,000 | +88.5% | 200,364 | +59.5% | 0.00% | – |
| Q2 2017 | $1,759,000 | -34.5% | 125,624 | -3.8% | 0.00% | -100.0% |
| Q1 2017 | $2,684,000 | +60.2% | 130,645 | +10.7% | 0.00% | – |
| Q4 2016 | $1,675,000 | +6.6% | 117,973 | +60.6% | 0.00% | – |
| Q3 2016 | $1,571,000 | -8.0% | 73,444 | -3.3% | 0.00% | – |
| Q2 2016 | $1,708,000 | +17.3% | 75,926 | -0.8% | 0.00% | – |
| Q1 2016 | $1,456,000 | -27.5% | 76,528 | +0.7% | 0.00% | – |
| Q4 2015 | $2,007,000 | +34.7% | 75,985 | +60.2% | 0.00% | – |
| Q3 2015 | $1,490,000 | +1485.1% | 47,432 | +2555.8% | 0.00% | – |
| Q2 2015 | $94,000 | +9300.0% | 1,786 | +9822.2% | 0.00% | – |
| Q1 2015 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |